Skip to content

The Supply chain Health INitiative Evaluation (SHINE) study protocol: Evaluating health and wellbeing services delivered through the supply chain.

A prospective matched control cluster study to assess the effectiveness of health and wellbeing services (HWS) delivered by large enterprise organisations (LEOs) to small and medium sized enterprises (SME) on employees’ work engagement, and exploration of SME decision makers’ willingness and capacity to purchase different types of HWS from their LEO.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17324653
Enrollment
1170
Registered
2026-03-31
Start date
2026-01-27
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General health and wellbeing. No specific health condition(s) or problem(s) to be studied in this study. Other

Interventions

This is a prospective matched cluster randomised controlled trial. All SMEs have been randomly sorted into either the intervention or control arm of the study. Randomisation was conducted via a comput

Sponsors

Guy's and St Thomas' NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 101 Years

Inclusion criteria

Inclusion criteria: For the SMEs (or clusters): 1. UK-based company with between 10 and 249 staff 2. Operate independently, i.e. not be managed by a larger parent company or conglomerate. Within the participating SMEs, the study will be implemented at an organisational-level: 1. All employees will be eligible to take part in the study 2. Salaried employees and others that SMEs deem appropriate to involve, e.g. those undertaking apprenticeships, contactors, or volunteers. 3. All participants will be of working age, i.e. 16+ years.

Exclusion criteria

Exclusion criteria: For the SMEs (or clusters): 1. Any companies that were not solely based in the UK 2. Companies that had nine or fewer employees, or 250 or more employees. 3. Companies that operated and were managed by a larger conglomerate. We acknowledge that while many companies have nine or fewer employees and may also benefit from HWS delivered by LEOs with whom they work, we have not included them due to statistical concerns related to small sample sizes. Companies with 250 or more employees are not classed as an SME in the UK. Companies that operated as a conglomerate were excluded because the large parent company may offer health and wellbeing services to the SMEs that they work with, hence contaminating any effect we might observe from the LEO-delivered intervention. Employees: 1. If they were not currently working with one of the participating sites 2. If they were 15 years of age or younger

Countries

England, United Kingdom

Contacts

Public ContactBrendan Dempsey
brendan.dempsey@nhs.net-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 8, 2026